3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
18
Prostatic Neoplasms
16
Colorectal Neoplasms
14
Neoplasms
12
Hematopoietic and Lymphatic System Neoplasm
12
Lung Neoplasms
9
Hematologic Neoplasms
8
Ovarian Neoplasms
5
Multiple Myeloma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Malignant Solid Neoplasm
4
Lymphoma
4
Urinary Bladder Neoplasms
3
Hematopoietic and Lymphoid System Neoplasm
3
Advanced Malignant Solid Neoplasm
3
Triple Negative Breast Neoplasms
2
Thyroid Cancer, Papillary
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Obesity-Related Malignant Neoplasm
2
Mouth Neoplasms
2
Motor Activity
2
Melanoma
2
Malignant Female Reproductive System Neoplasm
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Genetic Predisposition to Disease
2
Interventions
Paclitaxel
8
Hyperthermic Intraperitoneal Chemotherapy
6
Mitomycin
5
Cisplatin
5
Fluorouracil
4
Bevacizumab
4
Oxaliplatin
3
Leucovorin
3
Doxorubicin
3
Cytoreduction Surgical Procedures
3
Carboplatin
3
Blood Specimen Collection
3
sodium thiosulfate
2
pembrolizumab
2
Standard of Care
2
Laparoscopy
2
soluble LAG-3 protein, human
1
relacorilant
1
oregovomab
1
olaparib
1
nilotinib
1
liposomal doxorubicin
1
irinotecan sucrosofate
1
dehydroftorafur
1
avelumab
1
X-Rays
1
Topotecan
1
Taxes
1
Specimen Handling
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Peritoneal Neoplasms
×
Interviews as Topic
×
1 year
×
Clear all
No trials found.